For more than two decades, research has called into question a purely pathoanatomical basis for axial pain and its treatment. It also is well established that spine treatments are often of limited benefit. In an environment of spiraling disability, heavy investment in purely biomedical spine care has led to skyrocketing health costs, heightened stakeholder scrutiny and calls for improved cost-to-outcome value.

Concurrently, extensive science has shown that psychosocial factors are probably more predictive of the transition from acute to chronic and disabling spine pain. Data supporting the importance of early return to normal activity and work have elevated the importance of effective screening and management of nonphysical barriers to recovery.

This course assembles thought and research leaders in an in-depth conference on spine care as informed by the latest science on the neurophysiology and neuropsychological aspects of pain, risk screening and modification, current and future provider training, developing psychologically-informed care teams and identifying and overcoming barriers to the implementation of a biopsychosocial care model.

View Agenda